Cleared Traditional

BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY

K140446 · Becton, Dickinson & CO · Microbiology
May 2014
Decision
88d
Days
Class 1
Risk

About This 510(k) Submission

K140446 is an FDA 510(k) clearance for the BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY, a Dna Probe, Nucleic Acid Amplification, Chlamydia (Class I — General Controls, product code MKZ), submitted by Becton, Dickinson & CO (Sparks, US). The FDA issued a Cleared decision on May 20, 2014, 88 days after receiving the submission on February 21, 2014. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3120.

Submission Details

510(k) Number K140446 FDA.gov
FDA Decision Cleared SESE
Date Received February 21, 2014
Decision Date May 20, 2014
Days to Decision 88 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code MKZ — Dna Probe, Nucleic Acid Amplification, Chlamydia
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3120

Similar Devices — MKZ Dna Probe, Nucleic Acid Amplification, Chlamydia

All 18
Aptima? Chlamydia trachomatis Assay
K230451 · Hologic, Inc. · Nov 2023
COBAS 4800 CT / NG TEST
K110923 · Roche Molecular Systems, Inc. · Jan 2012
BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAY
K091724 · Becton, Dickinson & CO · Nov 2009
BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY
K090824 · Becton, Dickinson & CO · Jun 2009
BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAY
K081824 · Becton, Dickinson & CO · Dec 2008
ABBOTT REALTIME CT/NG ASSAY AND MULTI-COLLECT SPECIMEN COLLECTION KIT
K080739 · Abbott Molecular, Inc. · Jul 2008